Clinical Trial

Non-Narcotic Pain Control After ACL Reconstruction

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a double-blind randomized controlled trial of standard of care therapy, either oral ketorolac (experimental group) or oral oxycodone (control group) to demonstrate efficacy in reducing the percentage of narcotic doses taken and documenting the number of patients with no exposure to any narcotics (take zero oxycodone) after undergoing primary knee ACL reconstruction outpatient surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-07; most recent amendment 2026-06-12.
Status change: Recruiting → Active, Not Recruiting 2026-06-12
Trial Details
NCT Number NCT06973785
Lead Sponsor The Cleveland Clinic
Conditions ACL - Anterior Cruciate Ligament Rupture, ACL Injuries
Enrollment 30 participants
Start Date 2025-07-15
Primary Completion 2026-06-12 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-15